CAS 1023650-66-9

PF-3882845

CAS : 1023650-66-9

PF-3882845

Degré de pureté : ≥98%

Masse moléculaire : 419.9g/mol

Ref: 54-BUP01825

PF-03882845

CAS : 1023650-66-9

PF-03882845 is a selective small molecule inhibitor of Janus kinase 3 (JAK3), which is derived from a pharmaceutical synthesis process. Its mode of action involves targeting and inhibiting the JAK3 enzyme, a crucial component of the JAK-STAT signaling pathway, which is integral to immune system function and various cellular processes. By specifically inhibiting JAK3, PF-03882845 interferes with the signaling pathways that rely on this kinase, potentially modulating immune responses.

Formule : C₂₄H₂₂ClN₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 419.9 g/mol

Ref: 3D-YQB65066

PF-3882845

CAS : 1023650-66-9

PF-3882845, a high affinity MR antagonist (IC50=2.7 nM) for hypertension, also targets progesterone receptor (IC50: 310 nM).

Formule : C₂₄H₂₂ClN₃O₂

Degré de pureté : 99.63%

Couleur et forme : Solid

Masse moléculaire : 419.9

Ref: TM-T16502